Screening for mutations in Colombian metastatic non-small cell lung cancer (NSCLC) patients (ONCOLGroup).

被引：0
|
作者：
Cardona, A. F.
Ramos, P. L.
Duarte, R.
Carranza, H.
Castro, C. J.
Lema, M.
Vargas, C. A.
Jimenez, A.
Becerra, H. A.
Rosell, R.
机构：
[1] Fdn Santa Fe Bogot, Bogota, Colombia
[2] Sanitas, Bogota, Colombia
[3] Clin Astorga, Medellin, Colombia
[4] Inst Cancerl, Medellin, Colombia
[5] Catalan Inst Oncol, Barcelona, Spain
[6] USP Inst Univ Dexeus, Pangaea Biotech, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.7577
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7577
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The Checkpoint Inhibitors for the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)
    Hirsh, Vera
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [22] Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)
    Nagasaka, Misako
    Asad, Mohammad Fahad B.
    Al Hallak, Mohammed Najeeb
    Uddin, Md Hafiz
    Sukari, Ammar
    Baca, Yasmine
    Xiu, Joanne
    Magee, Dan
    Mamdani, Hirva
    Uprety, Dipesh
    Kim, Chul
    Xia, Bing
    Liu, Stephen, V
    Nieva, Jorge J.
    Lopes, Gilberto
    Bepler, Gerold
    Borghaei, Hossein
    Demeure, Michael J.
    Raez, Luis E.
    Ma, Patrick C.
    Puri, Sonam
    Korn, W. Michael
    Azmi, Asfar S.
    LUNG CANCER, 2021, 160 : 92 - 98
  • [23] A survey on insomnia in patients with non-small cell lung cancer (NSCLC)
    Subramanian, J.
    Baggstrom, M. Q.
    Gilstrap, E.
    De Shields, T.
    Boehmer, L.
    Williams, K.
    Devarakonda, S.
    Gao, F.
    Govindan, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Genomic landscape of patients with non-small cell lung cancer (NSCLC)
    Singh, Neeraj Kumar
    Saini, Kamal S.
    Chakkrapani, Sangavai
    Severson, Eric
    Nagaraj, Nahush
    Ramkissoon, Shakti
    Chico, Isagani
    Aguilo, Ariel
    George, Rohini
    Vidal, Laura
    Agrawal, Smita
    CANCER RESEARCH, 2023, 83 (07)
  • [25] Prognostic significance and origin of plasma KRAS mutations in patients with non-small cell lung cancer (NSCLC)
    Gautschi, Oliver
    Ziegler, Annemarie
    Huegli, Barbara
    Gugger, Mathias
    Ratschiller, Daniel
    Mack, Philip C.
    Kung, Hsing-Jien
    Stahel, Rolf A.
    Gandara, David R.
    Betticher, Daniel C.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S443 - S443
  • [26] Occurrence and characteristics of KEAP1-mutations in patients with non-small cell lung cancer (NSCLC)
    Frank, R.
    Scheffler, M.
    Michels, S.
    Koenig, K.
    Merkelbach-Bruse, S.
    Serke, M.
    Ko, Y. -D
    Gerigk, U.
    Geist, T.
    Heukamp, L.
    Buettner, R.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 8 - 8
  • [27] Exploring the association between KRAS mutations and depression in non-small cell lung cancer (NSCLC) patients
    Li, Jenny Jing
    Harper, Jessica
    Bhulani, Nizar
    Gerber, David E.
    Khan, Saad A.
    Madrigales, Alejandra
    Gates, Samantha
    Toups, Marisa
    Beg, Muhammad Shaalan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31)
  • [28] Optimum timing of gefitinib therapy in metastatic non-small cell lung cancer (NSCLC) patients.
    Ayllon, J
    Plazanet, V
    Guillevin, EF
    Banu, E
    Bonan, B
    Oudard, S
    Barthes, FP
    Theou, N
    Sors, H
    Andrieu, JM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 700S - 700S
  • [29] CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS OF METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS IN MEXICO
    Flores-Caballero, M. A.
    Lugo-Martinez, G.
    Rodriguez-Cid, J. R.
    Juarez-Vignon Whaley, J.
    Martinez-Herrera, J. F.
    Cruz-Zermeno, M.
    Seidman-Sorsby, A.
    Garcia-Montes, V
    Garibay-Diaz, J. C.
    Gonzalez Espinosa, I
    Hernandez-Flores, O.
    Oyervides-Juarez, V. M.
    Lopez Lopez, F.
    Gonzalez-Cisneros, P.
    Riera Sala, R.
    Alatorre-Alexander, J.
    Dorokhova, E.
    Betancur, M. A.
    Medina, S.
    Flores-Garcia, L.
    Amaya-Gutierrez, M. J.
    Rodriguez-Rosales, Y.
    VALUE IN HEALTH, 2023, 26 (12) : S238 - S238
  • [30] KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients
    Garzon, Monica
    Villatoro, Sergi
    Teixido, Cristina
    Mayo, Clara
    Martinez, Alejandro
    Llanos Gil, Maria de Los
    Viteri, Santiago
    Morales-Espinosa, Daniela
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (05) : 511 - 516
12345